New Phase 2 study shows that the drug sotatercept successfully reduces lung blood pressure and improves heart function in patients with a severe form of heart failure.
Most Recent Articles
Artificial Intelligence and 3D Modeling for Physiological Guidance of Coronary Stenting
A large-scale clinical trial confirms that AI-powered software can assess heart blockages as accurately as invasive wire-based tests, potentially making heart procedures faster and safer.
Catheter Ablation vs. Edoxaban Alone for Secondary Stroke Prevention: The STABLED Trial
A major clinical trial reveals that adding catheter ablation to standard blood thinners fails to significantly lower the risk of repeat strokes in high-risk atrial fibrillation patients.
Randomized Comparison of Coronary Recanalization Versus Placebo for Chronic Occlusion
A landmark double-blind study proves that nonsurgical procedures to clear totally blocked heart arteries can provide 31 extra days of relief from chest pain annually.
Discovery of DOPA Decarboxylase as a High-Specificity Biomarker for Parkinson’s Disease
A newly discovered biomarker in spinal fluid can diagnose Parkinson’s and Lewy body dementia with over 90% accuracy, potentially ending frequent misdiagnoses between these conditions and Alzheimer’s.